Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

[1]  E. Mitchell,et al.  The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. , 1990, The American review of respiratory disease.

[2]  P. O'Byrne,et al.  Urinary leukotriene E4 levels during early and late asthmatic responses. , 1990, The Journal of allergy and clinical immunology.

[3]  R. Keith,et al.  The preclinical pharmacology of ICI 204,219. A peptide leukotriene antagonist. , 1990, The American review of respiratory disease.

[4]  L. Smith,et al.  Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects. , 1990, The American review of respiratory disease.

[5]  L. Smith,et al.  Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219. , 1990, The American review of respiratory disease.

[6]  S. Holgate,et al.  Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects. , 1990, Journal of applied physiology.

[7]  P. Sterk,et al.  The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. , 1990, The American review of respiratory disease.

[8]  S. Durham,et al.  Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. , 1989, The American review of respiratory disease.

[9]  C T Dollery,et al.  Effect of the oral leukotriene D4 antagonist LY171883 on inhaled and intradermal challenge with antigen and leukotriene D4 in atopic subjects. , 1989, The Journal of allergy and clinical immunology.

[10]  S. Holgate,et al.  Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. , 1989, Journal of applied physiology.

[11]  C. Dollery,et al.  URINARY LEUKOTRIENE E4 AFTER ANTIGEN CHALLENGE AND IN ACUTE ASTHMA AND ALLERGIC RHINITIS , 1989, The Lancet.

[12]  S. Holgate,et al.  Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. , 1989, Journal of applied physiology.

[13]  T. Lee.  Pharmacological modulation of leukotriene and platelet activating factor biosynthesis and activities by alternative dietary fatty acids. , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  J. Arm,et al.  The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. , 1988, The Journal of allergy and clinical immunology.

[15]  K. Chung,et al.  Inflammatory mediators and asthma. , 1988, Pharmacological reviews.

[16]  S. Holgate,et al.  Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man. , 1987, Thorax.

[17]  S. Holgate,et al.  The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. , 1987, The American review of respiratory disease.

[18]  D. Cockcroft,et al.  Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. , 1987, The Journal of allergy and clinical immunology.

[19]  N. Barnes,et al.  The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. , 1987, The Journal of allergy and clinical immunology.

[20]  P. O'Byrne,et al.  The origin of airway hyperresponsiveness. , 1986, The Journal of allergy and clinical immunology.

[21]  S. Rak,et al.  Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season. , 1985, The Journal of allergy and clinical immunology.

[22]  R. Naclerio,et al.  Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. , 1984, The New England journal of medicine.

[23]  E. R. Mcfadden,et al.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.

[24]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[25]  N. Thomson,et al.  Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. , 1983, The Journal of allergy and clinical immunology.

[26]  F. Hargreave,et al.  Bronchial reactivity to inhaled histamine: a method and clinical survey , 1977, Clinical allergy.